SYRS

Syros Pharmaceuticals, Inc. Common Stock
SYRS

Overview Fund Activity
Delisted

SYRS was delisted on the 19th of March, 2025.

Back to rankings

64 hedge funds and large institutions have $266M invested in Syros Pharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
-6
Holders Change %
-8.57%
% of All Funds
1.41%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
12
Increased
22
Reduced
22
Closed
17
Calls
$611K
Puts
–
Net Calls
+$611K
Net Calls Change
-$345K

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$13.5M
2
AIM
ARK Investment Management
Florida
+$4.87M
3
AG
Artal Group
Luxembourg
+$3M
4
PCM
Portolan Capital Management
Massachusetts
+$1.1M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$851K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$3.63M
2
AVM
Arch Venture Management
Illinois
-$1.48M
3
Renaissance Technologies
Renaissance Technologies
New York
-$892K
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$383K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$369K
Name Holding Trade Value Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$37.2M +$851K +14,357 +2%
AIM
2
ARK Investment Management
Florida
$35M +$4.87M +82,159 +16%
NAMA
3
Nikko Asset Management Americas
New York
$29.2M -$293K -4,945 -1%
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$29.2M -$293K -4,945 -1%
AVM
5
Arch Venture Management
Illinois
$18.2M -$1.48M -25,000 -8%
FP
6
Flagship Pioneering
Massachusetts
$17.4M – – –
BlackRock
7
BlackRock
New York
$16.7M -$281K -4,746 -2%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$13.5M +$13.5M +227,500 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$10.7M +$7.53K +127 +0.1%
SB
10
Samsara BioCapital
California
$9.6M – – –
DM
11
Deerfield Management
New York
$7.53M – – –
JPMorgan Chase & Co
12
JPMorgan Chase & Co
New York
$5.23M -$383K -6,455 -7%
BBA
13
Baker Bros. Advisors
New York
$4.09M – – –
State Street
14
State Street
Massachusetts
$3.87M -$177K -2,983 -4%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$3.34M +$369K +6,224 +12%
PCM
16
Portolan Capital Management
Massachusetts
$3.04M +$1.1M +18,572 +57%
AG
17
Artal Group
Luxembourg
$3M +$3M +50,614 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$2.95M +$134K +2,264 +5%
SCM
19
Sio Capital Management
New York
$2.78M +$119K +2,000 +4%
Northern Trust
20
Northern Trust
Illinois
$2.42M +$34.6K +584 +1%
RG
21
Redmile Group
California
$1.26M – – –
Charles Schwab
22
Charles Schwab
California
$1.22M -$1.07K -18 -0.1%
Nuveen Asset Management
23
Nuveen Asset Management
Illinois
$822K -$11.9K -200 -1%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$692K +$32K +540 +5%
Invesco
25
Invesco
Georgia
$534K +$534K +9,001 New
1
2 3 4